Hints and tips:
Related Special Reports
...Five of the companies, including ArriVent Biopharma and Dianthus Therapeutics, informed investors that they were exploring alternative manufacturing options to WuXi....
...Chief financial officer Becky Worthington told the Financial Times the company was negotiating with lenders and reviewing its options for a further £900mn of debt it aims to extend or refinance before the...
...Amazon is being threatened with legal action from the US medicines watchdog over the sales of “unapproved” drugs on its online site, as the tech giant faces scrutiny while seeking to break further into the...
...But more research will be needed before organoids can replace or supplement failed organs....
..., dietary supplements, sleep monitors and temperature control equipment and the figure could be approaching $300bn....
...GSK, the British pharma group, has struck a $1.4bn deal to acquire Anglo-American biotech Aiolos Bio, which makes respiratory medicines....
...Infections from multi-drug resistant bacteria cause an estimated 35,000 deaths in the EU every year, according to the European Medicines Agency....
...GSK’s Nigeria affiliate also scaled back its business last year, shutting down the distribution of its own medicines and switching to third-party Nigerian companies....
...chief scientific officer of GSK, said the asthma drug could “expand the reach of our current respiratory biologics portfolio, including to the 40 per cent of severe asthma patients . . . where treatment options...
...Like a Spac, ContextLogic could supplement its firepower with a private equity firm providing the capital infusion needed to buy a larger business, its management said....
...Stephen Ubl, PhRMA chief executive, said on Friday that the FDA decision was “reckless” and that the lobby group was considering “all options” to prevent the policy from harming patients....
...But the decision reignites debate about the pricing of cell and gene therapies, which offer revolutionary new treatments and sometimes cures for patients with very few other options....
...“This study is an important milestone in genomic medicine,” said Nirupa Murugaesu of Guy’s and St Thomas’ NHS Trust, one of the project leaders....
...Bank loans often aren’t their best option, or are no option at all, because they lack established revenue streams or collateral....
...About 60 per cent of the job categories in the late 2010s did not exist in 1940 — in medicine, software, entertainment and solar power, for example....
...Studies show that many individuals fail to enrol, take money out when they change jobs or chose overly conservative options. “All the risks have slowly moved over to the participant . . ....
...“We’re technology-agnostic on all of the options that are out there,” Dominguez said. “Wind propulsion is one.”...
...What happens when someone with ADHD doesn’t get the medicine they need? How does it affect their working life and what can managers do to help people who are struggling?...
...This grizzly trade involved farmers seeking to supplement their meagre incomes by selling blood — sometimes as often as twice a day — at counters run either by local health authorities or by illegal “bloodmongers...
...“This cannot be the only option, otherwise famine will overtake many more people,” Hanna said....
...Your first step could be to explore options within the clinical world where you can continue to practice as a doctor....
...And then an increasing annuity is the only sensible option. The increasing annuity figures didn’t look nearly so alluring as the level ones....
...To compensate him for $160mn in options he gave up on leaving Expedia, Uber agreed that he would receive options over 1.75mn shares if the $120bn target was met and he stayed in post for five years....
...That is likely to help drive the “rapid growth” the business is experiencing as patients seek “more convenient options to engage with their healthcare”, John Love, general manager and vice-president of Amazon...
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
International Edition